K. Ishida

Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats

Y. Ohno, K. Okada, Mitsutaka Nakamura, 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effects of chronic treatments with SM-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivities in rats.

Y. Ohno, K. Ikeda, M. Nakamura, 1995, General pharmacology.

The Comet Assay with Multiple Mouse Organs: Comparison of Comet Assay Results and Carcinogenicity with 208 Chemicals Selected from the IARC Monographs and U.S. NTP Carcinogenicity Database**

S. Tsuda, K. Sekihashi, A. Saga, 2000, Critical reviews in toxicology.

Evaluation of bradykinesia induction by SM-9018, a novel 5-HT2 and D2 receptor antagonist, using the mouse pole test

Y. Ohno, K. Okada, K. Ikeda, 1994, Pharmacology Biochemistry and Behavior.

Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum.

Y. Ohno, K. Ikeda, M. Nakamura, 1996, European journal of pharmacology.

Effects of SM-9018, a novel 5-HT2 and D2 receptor antagonist, on electrically-evoked [3H]acetylcholine release from rat striatal slices.

Y. Ohno, M. Nakamura, T. Ishibashi, 1996, General pharmacology.